Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Detail Textuals 2)

v3.10.0.1
Stock-Based Compensation (Detail Textuals 2) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 25, 2018
Feb. 28, 2018
Jan. 18, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense       $ 100,602 $ 152,171 $ 330,212 $ 304,338
Total amount of unrecognized compensation cost       $ 678,514   $ 678,514  
Recognized weighted average period           2 years 3 months 18 days  
Restricted stock awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Fair market value of shares granted     $ 475,000        
Restricted stock vesting percentage     50.00%        
Restricted stock awards | K2C, Inc.              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of restricted common stock granted   900,000          
Stock compensation expenses           $ 216,000  
Restricted stock awards | Dr. Murphy              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of restricted common stock granted     900,000        
Restricted stock awards | Elizabeth Berecz, CFO              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of restricted common stock granted 700,000   700,000        
Stock compensation expenses           $ 184,800  
Restricted stock awards | Cosmas N. Lykos              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of restricted common stock granted     900,000